p53 and MDM2 in the development and progression of bladder cancer

European Urology

Volumn 32, Issue 4, 1997, Pages 487-493

  Schmitz Drager, B J ^a   Kushima, M ^a   Goebell, P ^a   Jax, T W ^a   Gerharz, C D ^a   Bultel, H ^a   Schulz, W A ^a   Ebert, T ^a   Ackermann, R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bladder cancer, prognosis; Carcinoma in situ; Dysplasia; MDM2, oncogene; p53, tumor suppressor gene

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CARCINOMA IN SITU; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; SUPERFICIAL CANCER; TUMOR SUPPRESSOR GENE;

EID: 0030727975     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000480813     Document Type: Article

References (33)